Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0650

+0.2%

Nov 18 12:36 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Howard Williams who wrote (11917)	5/13/2013 7:59:49 AM
From: NTTG	3 Recommendations Read Replies (1) of 13111

What is new here...Oh I see it... they are suggesting that progression free survival in non-nodal stage III is longer than stage IV disease as a result of PV-10...really? Not simply the result of natural disease history? This is as meaningful as the strategy of trying to compare 'responders' and 'non-responders' in their PII trial dataset years ago....... Long lists of re-cycled data presentations from 2010 to 1012 is churning, no progress there The PH-10 discussion is simple smoke and mirrors Jack, this is the stuff I am talking about

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next